Has Minela Avdic received payments from drug or device companies?

Yes. Drug and device makers reported $7,138 in general payments to Minela Avdic across 410 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Minela Avdic did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Minela Avdic come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Minela Avdic

Psychiatry · Paramus, NJNPI 1902542178

Payments from drug & device makers

$7,138in general payments, 2019–2025

Across 410 payments — averaging $17.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Otsuka America Pharmaceutical, Inc.$1K
Neurocrine Biosciences, Inc.$1K
Vanda Pharmaceuticals Inc.$898
Teva Pharmaceuticals USA, Inc.$809
Alkermes, Inc.$556
Supernus Pharmaceuticals, Inc.$503
plus $2K from 17 others

What the payments were for

Food & beverage$7,137100%
Education$10%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Otsuka America Pharmaceutical, Inc.	63	$1,266
Neurocrine Biosciences, Inc.	58	$1,011
Vanda Pharmaceuticals Inc.	50	$898
Teva Pharmaceuticals USA, Inc.	37	$809
Alkermes, Inc.	33	$556
Supernus Pharmaceuticals, Inc.	18	$503
AbbVie	43	$444
Corium, LLC	28	$428
Lundbeck LLC	16	$247
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	10	$180
Axsome Therapeutics, Inc.	10	$175
Sunovion Pharmaceuticals Inc.	13	$154
Takeda Pharmaceuticals U.S.A., Inc.	6	$86
Idorsia Pharmaceuticals US Inc	5	$73
Almatica Pharma LLC	5	$71
Sage Therapeutics, LLC	3	$61
Johnson & Johnson	3	$43
Bausch Health US, LLC	2	$33
E.r. Squibb & Sons, L.L.C.	2	$31
OWP Pharmaceuticals, Inc.	2	$28
Neos Therapeutics, LP	1	$17
Avanir Pharmaceuticals, Inc.	1	$15
Noven Therapeutics, LLC	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,138 in reported general payments places this provider in the 90th percentile of 1,119 psychiatry providers in New Jersey.

See all psychiatry providers in New Jersey →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
IngrezzaValbenazine Tosylate	18	$135,540
VraylarCariprazine Hcl	31	$43,575
RexultiBrexpiprazole	20	$38,053
LybalviOlanzapine/Samidorphan Malate	13	$23,597
Ziprasidone Hcl	25	$2,855
Divalproex Sodium	51	$2,681
Quetiapine Fumarate	124	$2,454
Lurasidone Hcl	26	$2,439
Paliperidone ErPaliperidone	15	$2,231
Olanzapine	69	$2,046
Vilazodone Hcl	45	$2,031
Sertraline Hcl	222	$1,976
Risperidone	98	$1,511
Bupropion XlBupropion Hcl	56	$1,472
Buspirone Hcl	132	$1,449

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza	$1,011	$135,54018 claims
AbbVieVraylar	$444	$43,57531 claims
Otsuka America Pharmaceutical, Inc.Rexulti	$1,266	$38,05320 claims
Alkermes, Inc.Lybalvi	$556	$23,59713 claims
Almatica Pharma LLCSertraline Hcl	$71	$1,976222 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,119 psychiatry providers in New Jersey.

Other psychiatry in Paramus

Aijaz NanjianiParamus$95K
Yasir AhmadParamus$39K
Monica DhingraParamus$28K
Leon RosenbergCherry Hill$6.4M
Steven GlassClementon$3.9M
Judith JosephPaterson$3.8M
Jeffrey ApterPrinceton$1.7M
Roberta BallCherry Hill$741K
Marc CantillonLivingston$524K
Sanjay VarmaPrinceton$479K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →